Karen Kalayajian - Net Worth and Insider Trading

Karen Kalayajian Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karen Kalayajian owns 1 companies in total, including Intelgenx Technologies Corp (IGXT) .

Click here to see the complete history of Karen Kalayajian’s form 4 insider trades.

Insider Ownership Summary of Karen Kalayajian

Ticker Comapny Transaction Date Type of Owner
IGXT Intelgenx Technologies Corp 2023-04-13 VP & Finance&Admin - Subsidiary

Karen Kalayajian Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Karen Kalayajian Ownership Network

Ownership Network List of Karen Kalayajian

No Data

Ownership Network Relation of Karen Kalayajian


Karen Kalayajian Owned Company Details

What does Intelgenx Technologies Corp do?

Who are the key executives at Intelgenx Technologies Corp?

Karen Kalayajian is the VP & Finance&Admin - Subsidiary of Intelgenx Technologies Corp. Other key executives at Intelgenx Technologies Corp include 10 percent owner Atai Life Sciences N.v. , 10 percent owner Atai Life Sciences Ag , and CEO Dwight Gorham .

Intelgenx Technologies Corp (IGXT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Intelgenx Technologies Corp (IGXT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intelgenx Technologies Corp (IGXT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Intelgenx Technologies Corp (IGXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Intelgenx Technologies Corp Insider Transactions

No Available Data

Karen Kalayajian Mailing Address

Above is the net worth, insider trading, and ownership report for Karen Kalayajian. You might contact Karen Kalayajian via mailing address: 4896 Rue Edouard-brunette, Laval A8 H7t 0j4.

Discussions on Karen Kalayajian

No discussions yet.